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weight counterparts, or even a lower mortality risk
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relationship between BMI and mortality in
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F I G U R E 2 Interaction Plot Between BMI and Sex for Nonischemic Etiology and Ischemic Etiology

(A) Nonischemic etiology; (B) ischemic etiology. Model adjusted for age, race, left ventricular ejection fraction, etiology, New York Heart
Association, digoxin, angiotensin converting enzyme inhibitor/angiotensin receptor blocker, beta blocker, diabetes, smoking, hypertension,
hyperlipidemia, atrial ﬁbrillation, rest systolic blood pressure, heart rate recovery, peak oxygen uptake, respiratory exchange rate, peak tidal
volume, heart transplantation, or left ventricular assist device placement. The nonparallel lines conﬁrm a differing relationship between BMI as
a continuous value (x axis) and adjusted mortality HR (y axis) in females versus males. For females, the lowest mortality hazard was seen just
below BMI 30 kg/m2, with higher HRs in the NW (<25 kg/m2) and stage II/III obesity (>35 kg/m2) regions of the x axis. Males had a higher
mortality hazard overall and showed an increased mortality hazard in the OW and OB ranges as compared with the NW range. BMI
index; NW

normal weight; OW

body mass

overweight.

mortality and 9% decrease in 1-year mortality per
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